Karly A Achtymichuk1, Jeffrey A Johnson2, Fatima Al Sayah3, Dean T Eurich4. 1. School of Public Health, University of Alberta, 3-300 Edmonton Clinic Health Academy, 11405-87 Ave, Edmonton, AB, Canada T6G 1C9; ACHORD, 2-040 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada T6G 2E1. Electronic address: karlya@ualberta.ca. 2. School of Public Health, University of Alberta, 3-300 Edmonton Clinic Health Academy, 11405-87 Ave, Edmonton, AB, Canada T6G 1C9; ACHORD, 2-040 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada T6G 2E1. Electronic address: jeff.johnson@ualberta.ca. 3. ACHORD, 2-040 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada T6G 2E1. Electronic address: falsayah@ualberta.ca. 4. School of Public Health, University of Alberta, 3-300 Edmonton Clinic Health Academy, 11405-87 Ave, Edmonton, AB, Canada T6G 1C9; ACHORD, 2-040 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada T6G 2E1. Electronic address: deurich@ualberta.ca.
Abstract
OBJECTIVE: Epidemiological research has posited a 'healthy user' bias in patients receiving influenza vaccination; thus we sought to evaluate potential healthy-user attributes and their associations with influenza vaccination. RESEARCH DESIGN & METHODS: Between 2011 and 2013, adults with type 2 diabetes were enrolled in a prospective cohort in Alberta, Canada. Information collected included sociodemographics, diabetes-related data (e.g., duration, complications), health behaviors (e.g., smoking status), functional health status, and satisfaction with healthcare. Data were collected by a mailed, self-administered survey. Multivariable logistic regression analyses were used to identify potential healthy-user attributes independently associated with influenza vaccination. RESULTS: From a cohort of 2040 patients, 1287 (63%) reported receiving the influenza vaccine in the previous year. Average age of the cohort was 64 years (standard deviation 11) and 55% were male. In multivariable analysis, attributes independently associated with influenza vaccination included receiving preventive medications: aspirin (64% vs 44%; adjusted odds ratio, aOR 1.65, 95% CI 1.34-2.04); blood pressure medications (76% vs 56%; aOR 1.36, 95% CI 1.07-1.71); and cholesterol-lowering medications (74% vs 53%; aOR 1.50, 95% CI 1.19-1.89), as well as having a healthcare professional check feet for lesions (47% vs 31%; aOR 1.39, 95% CI 1.12-1.74). Additional covariates independently associated with influenza vaccination included: age over 65 years, respiratory disease, the number of additional comorbidities, and higher ratings of healthcare experience. CONCLUSION: Vaccinated diabetic patients exhibit many postulated attributes of 'healthy users', which has implications for the interpretation of epidemiological studies of influenza vaccine effectiveness, as well as targeting future vaccination campaigns.
OBJECTIVE: Epidemiological research has posited a 'healthy user' bias in patients receiving influenza vaccination; thus we sought to evaluate potential healthy-user attributes and their associations with influenza vaccination. RESEARCH DESIGN & METHODS: Between 2011 and 2013, adults with type 2 diabetes were enrolled in a prospective cohort in Alberta, Canada. Information collected included sociodemographics, diabetes-related data (e.g., duration, complications), health behaviors (e.g., smoking status), functional health status, and satisfaction with healthcare. Data were collected by a mailed, self-administered survey. Multivariable logistic regression analyses were used to identify potential healthy-user attributes independently associated with influenza vaccination. RESULTS: From a cohort of 2040 patients, 1287 (63%) reported receiving the influenza vaccine in the previous year. Average age of the cohort was 64 years (standard deviation 11) and 55% were male. In multivariable analysis, attributes independently associated with influenza vaccination included receiving preventive medications: aspirin (64% vs 44%; adjusted odds ratio, aOR 1.65, 95% CI 1.34-2.04); blood pressure medications (76% vs 56%; aOR 1.36, 95% CI 1.07-1.71); and cholesterol-lowering medications (74% vs 53%; aOR 1.50, 95% CI 1.19-1.89), as well as having a healthcare professional check feet for lesions (47% vs 31%; aOR 1.39, 95% CI 1.12-1.74). Additional covariates independently associated with influenza vaccination included: age over 65 years, respiratory disease, the number of additional comorbidities, and higher ratings of healthcare experience. CONCLUSION: Vaccinated diabeticpatients exhibit many postulated attributes of 'healthy users', which has implications for the interpretation of epidemiological studies of influenza vaccine effectiveness, as well as targeting future vaccination campaigns.
Authors: Ludovic Casanova; Sébastien Cortaredona; Jean Gaudart; Odile Launay; Philippe Vanhems; Patrick Villani; Pierre Verger Journal: BMJ Open Date: 2017-08-18 Impact factor: 2.692
Authors: Jose J Zamorano-Leon; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Javier de-Miguel-Diez; David Carabantes-Alarcon; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; Khaoula Zekri-Nechar; Sara Sanz-Rojo Journal: J Clin Med Date: 2021-12-23 Impact factor: 4.241
Authors: Katie Gravagna; Christina Wolfson; Giorgia Sulis; Sarah A Buchan; Shelly McNeil; Melissa K Andrew; Jacqueline McMillan; Susan Kirkland; Nicole E Basta Journal: PLoS One Date: 2022-09-30 Impact factor: 3.752
Authors: Ibraheem M Alnaheelah; Nabil J Awadalla; Khalid M Al-Musa; Abdullah A Alsabaani; Ahmed A Mahfouz Journal: Int J Environ Res Public Health Date: 2018-07-01 Impact factor: 3.390